Vaccine Licensure

Legislation and/or Policy Statements

IOM Reports on Vaccine Safety



ACIP updates varicella vaccine recommendation, requiring immunity for child care and school entry

ACIP recommends an all-IPV schedule to begin January 2000 to prevent cases of vaccine-associated paralytic polio

AAP and PHS recommend removal of thimerosal from vaccines Also recommended postponement of hepatitis B vaccine from birth to 2-6 months for infants of hepatitis B surface antigen-negative mothers



Additional supply of thimerosal-free hepatitis B vaccine made available

MMWR notifies readers of the availability of a thimerosal-free hepatitis B vaccine, enabling the resumption of the birth dose



Pneumococcal vaccine for infants and young children licensed (Prevnar)

ACIP recommends pneumococcal vaccination for all children 2-23 months, and at-risk children 24-59 months (e.g., immunocompromised)




October: ACIP drafts statement expressing a preference for use of thimerosal-free DTaP, Hib, and Hep B vaccines by March 2002

Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism

Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement